Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results
de
Out of the Blue: An AJRCCM Podcast
2022-12-15 16:00:00
Fecha de lanzamiento
14:59
Duración
